Skip to main content
Premium Trial:

Request an Annual Quote

VA to Use Cepheid's Pathogen Tests in Hospitals

NEW YORK (GenomeWeb News) - Cepheid has inked two contracts with the Veterans Affairs Federal Supply Service Schedule to supply VA hospitals with its pathogen tests and its GeneXpert systems, and another with a Veteran's hospital chain in the northern Midwest, the company said today.
 
Under the Federal Supply agreements, Cepheid will supply its GeneXpert systems and its methicillin-resistant Staphylococcus aureus detection test, Xpert MRSA.
 
In a separate agreement, Cepheid also will supply the Veterans Integrated Services Network 12, also called the Great Lakes Health Care System, with the Xpert MRSA tests and the GeneXpert systems. The company said VISN 12 plans to conduct around 40,000 of the MRSA tests each year to help manage infection control.
 
Financial terms of the agreements were not released.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.